Celsion Receives Fast Track Designation For ThermoDox® Development Program To Treat Primary Liver Cancer
Celsion Receives Fast Track Designation For ThermoDox® Development Program To Treat Primary Liver Cancer
Celsion Corporation (Nasdaq: CLSN ), a leading oncology drug development company, today announced that the U.S. Food and Drug Administration (FDA) has designated the HEAT Study of its investigational drug, ThermoDox®, in combination with radiofrequency ablation (RFA), as a Fast Track Development Program.
Read more on PharmaceuticalOnline
Categories: Breast Cancer Risks Tags: cancer, Celsion, Designation, Development, fast, liver, Primary, program, receives, ThermoDox®, track, treat
Varian Medical Systems to Showcase Fast, Precise Brachytherapy Planning System at Annual Meeting of American …
Varian Medical Systems to Showcase Fast, Precise Brachytherapy Planning System at Annual Meeting of American …
A significantly more accurate* way of calculating the dosimetry of cancer treatments will be spotlighted by Varian Medical Systems at the American Association of Physicists in Medicine annual meeting at the Pennsylvania Convention Center in Philadelphia from July 18th-22nd.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: American, annual, Brachytherapy, fast, Medical, Meeting, planning, Precise, Showcase, system, Systems, Varian
ANyone know any good inspirational songs to dance to?? Fast speed. It’s for breast cancer awareness.?
I am on a dance team and we need an inspirational song to dance to for breast cancer awareness. any suggestions?
Jazz-hiphoppy type dance/.
Categories: Breast Cancer Awareness Tags: anyone, Awareness, breast, cancer, Dance, fast, good, inspirational, it's, Know, songs, speed
Keryx Biopharmaceuticals’ perifosine receives FDA Fast Track Designation
Keryx Biopharmaceuticals’ perifosine receives FDA Fast Track Designation
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company’s novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
Read more on News-Medical-Net
Categories: Breast Cancer Research Tags: Biopharmaceuticals', Designation, fast, Keryx, perifosine, receives, track
Special Report: Fast machines, genes and the future of medicine
Special Report: Fast machines, genes and the future of medicine
WASHINGTON/CHICAGO/LONDON (Reuters ) – Francis Collins, who helped map the human genome, did not get around to having his own genes analyzed until last summer. And he was surprised by what he learned.
Read more on Reuters